http://www.scleroweb.it/it/cosa-dobbiamo-aspettarci-da-brave-dreams-di-p-destro/

Translation:
Carry quote this question appeared on other shores, "what will produce the study Brave Dreams in more than what is already known?" Probably it is a question asked by many.

We answer: we do not know and nobody knows, and because of this we should expect their data to make a judgment. But something more we can say: in a first level of reasoning, the study Brave Dreams (now BD) can finally be answered if really scientific treatment of PTA in the multiple sclerosis leads one to a significant improvement in their quality of life, how much and in what forms of disease. I know many will say "but we already know"; you, anecdotally, but not scientifically, and not a day goes by that we feel right and left recite the De Profundis for this treatment. After BD, in case of positive results, this will not happen again, we could no longer attend workrooms, even published, conducted on small numbers of patients, that are bandied about as the proof of the end of the PTA, and this is independent from all disquisitions if it is the cause or not; if patients are better off in this level was considered scientifically significant, it will be much easier and quicker to adopt the procedure in hospitals. The second level of reasoning, not least, it follows from the first: if the treatment has a scientifically proven utility can be legitimately introduced in the LEA and then the virtuous circle that has always characterized the medicine applied, may have finally start seeing a large number of hospitals that will start and will contribute, in time, to refine the technique actively working with the research. According to you the first heart transplants had all the characteristics of efficacy and safety as they have today? No. And if he had not a widespread practice of interventional such transplants immediately today we are witnessing the evolution? I Have Not.

So the study Brave Dreams has a paramount importance for those who support the research and study of Prof. Zamboni, the Dott.Salvi and their team. We really can not stand the continuous commercialization statement that you are doing, even if legitimate, in private they mostly thought of accumulating huge gains, often trumpeting the imminent publication of data really interesting and not just statistics correspondence about who Multiple Sclerosis and CCSVI, or if the jugular angioplasty is safe or not. And then, if we conduct a rigorous scientific reasoning, reluctantly I note that even if a private clinic to publish a collection of data on the results of a large number of patients treated, what value would not have made a study with all the characteristics of science and independence from today we can no longer apart? And to think that is a very long time that we should not do without this method, I believe in 1611.

Paul Right

The Editors of ScleroWeb


COSA DOBBIAMO ASPETTARCI DA BRAVE DREAMS? di P.Destro
www.scleroweb.it
COSA DOBBIAMO ASPETTARCI DA BRAVE DREAMS? di P.Destro ScleroWeb ARTICOLI marzo 29, 2015 0 Comment 0 Tweet Riporto testualmente questa domanda apparsa in altri lidi: “cosa potrà produrre lo studio Brave Dreams in più di quello che non è già noto?” Probabilmente è una domanda che si pongono in molti.…